United Capital Financial Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.91M | Buy |
3,624
+57
| +2% | +$32K | 0.01% | 593 |
|
|
2026
Q1 | $2M | Buy |
3,567
+905
| +34% | +$580K | 0.01% | 547 |
|
|
2025
Q4 | $1.8M | Buy |
2,662
+127
| +5% | +$86.5K | 0.01% | 557 |
|
|
2025
Q3 | $1.62M | Buy |
2,535
+500
| +25% | +$303K | 0.01% | 516 |
|
|
2025
Q2 | $1.09M | Sell |
2,035
-200
| -9% | -$95.6K | 0.01% | 567 |
|
|
2025
Q1 | $939K | Sell |
2,235
-211
| -9% | -$91.6K | 0.01% | 577 |
|
|
2024
Q4 | $1.01M | Buy |
2,446
+22
| +0.9% | +$9.65K | 0.01% | 545 |
|
|
2024
Q3 | $1.22M | Buy |
2,424
+1
| +0% | +$486 | 0.01% | 497 |
|
|
2024
Q2 | $1.18M | Sell |
2,423
-61
| -2% | -$30.6K | 0.01% | 493 |
|
|
2024
Q1 | $1.34M | Sell |
2,484
-128
| -5% | -$70K | 0.01% | 503 |
|
|
2023
Q4 | $1.45M | Buy |
+2,612
| New | +$1.23M | 0.01% | 479 |
|
|
2023
Q3 | – | Sell |
-476
| Closed | -$239K | – | 864 |
|
|
2023
Q2 | $239K | Buy |
+476
| New | +$228K | ﹤0.01% | 818 |
|
|
2023
Q1 | – | Sell |
-7,447
| Closed | -$3.04M | – | 1013 |
|
|
2022
Q4 | $3.04M | Sell |
7,447
-106
| -1% | -$41.1K | 0.02% | 400 |
|
|
2022
Q3 | $2.46M | Sell |
7,553
-49
| -0.6% | -$18K | 0.01% | 435 |
|
|
2022
Q2 | $2.67M | Buy |
7,602
+115
| +2% | +$46.9K | 0.01% | 439 |
|
|
2022
Q1 | $4.1M | Sell |
7,487
-47
| -0.6% | -$24.7K | 0.02% | 394 |
|
|
2021
Q4 | $4.96M | Sell |
7,534
-232
| -3% | -$146K | 0.02% | 375 |
|
|
2021
Q3 | $4.83M | Sell |
7,766
-77
| -1% | -$51.7K | 0.02% | 381 |
|
|
2021
Q2 | $4.95M | Buy |
7,843
+16
| +0.2% | +$8.84K | 0.02% | 378 |
|
|
2021
Q1 | $3.83M | Sell |
7,827
-370
| -5% | -$185K | 0.02% | 397 |
|
|
2020
Q4 | $4.1M | Sell |
8,197
-519
| -6% | -$232K | 0.02% | 385 |
|
|
2020
Q3 | $3.43M | Sell |
8,716
-2,162
| -20% | -$799K | 0.02% | 400 |
|
|
2020
Q2 | $3.59M | Sell |
10,878
-10,502
| -49% | -$3.04M | 0.03% | 416 |
|
|
2020
Q1 | $5.18M | Sell |
21,380
-19,498
| -48% | -$5.09M | 0.04% | 332 |
|
|
2019
Q4 | $10.7M | Sell |
40,878
-33,657
| -45% | -$8.87M | 0.07% | 303 |
|
|
2019
Q3 | $20.3M | Buy |
74,535
+45,043
| +153% | +$12.5M | 0.14% | 170 |
|
|
2019
Q2 | $8.12M | Sell |
29,492
-18,160
| -38% | -$4.47M | 0.05% | 329 |
|
|
2019
Q1 | $10.7M | Buy |
47,652
+2,699
| +6% | +$557K | 0.07% | 284 |
|
|
2018
Q4 | $8.36M | Buy |
44,953
+5,659
| +14% | +$1.16M | 0.07% | 283 |
|
|
2018
Q3 | $9.81M | Buy |
39,294
+7,008
| +22% | +$1.7M | 0.07% | 304 |
|
|
2018
Q2 | $7.04M | Buy |
32,286
+13,670
| +73% | +$2.82M | 0.05% | 355 |
|
|
2018
Q1 | $3.56M | Sell |
18,616
-3,341
| -15% | -$617K | 0.03% | 465 |
|
|
2017
Q4 | $3.49M | Buy |
21,957
+10,399
| +90% | +$1.64M | 0.03% | 474 |
|
|
2017
Q3 | $1.8M | Sell |
11,558
-60
| -0.5% | -$9.49K | 0.02% | 608 |
|
|
2017
Q2 | $1.88M | Buy |
11,618
+1,426
| +14% | +$232K | 0.02% | 594 |
|
|
2017
Q1 | $1.58M | Buy |
10,192
+2,567
| +34% | +$354K | 0.01% | 621 |
|
|
2016
Q4 | $894K | Buy |
7,625
+1,410
| +23% | +$161K | 0.01% | 781 |
|
|
2016
Q3 | $701K | Buy |
6,215
+1,766
| +40% | +$186K | 0.01% | 872 |
|
|
2016
Q2 | $414K | Buy |
+4,449
| New | +$382K | ﹤0.01% | 957 |
|
Other funds holding IDXX
United Capital Financial Advisors's IDXX Position: Q2 2026 in Review
United Capital Financial Advisors increased its Idexx Laboratories (IDXX) stake by 1.6% in Q2 2026, buying an estimated $32K and bringing the position to 3,624 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #593.
United Capital Financial Advisors first reported a position in IDXX in Q2 2016 and has held it in 39 quarters since. The position peaked at $20.3M in Q3 2019. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- United Capital Financial Advisors held 3,624 shares of Idexx Laboratories worth $1.91M as of Q2 2026.
- United Capital Financial Advisors bought 57 Idexx Laboratories shares in Q2 2026, an estimated $32K.
- Idexx Laboratories made up 0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #593 holding.
- United Capital Financial Advisors first reported a position in Idexx Laboratories in Q2 2016 and has held it in 39 quarters since.
- United Capital Financial Advisors's Idexx Laboratories position peaked at $20.3M in Q3 2019.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.